Less common mutations associated with CH are mutations in the genes such as ASXL1 and TP53, which provide more prominent survival and growth advantage to the mutated hematopoietic cells, introducing a higher risk of progression to myeloid neoplasms [12,14]. The gene discussed is TP53; the disease is cyclic hematopoiesis.